Mark Holodniy MD
HIV/AIDS Medicine, Microbiology
Professor of Medicine Stanford University
Join to View Full Profile
3801 Miranda Ave# MailPalo Alto, CA 94304
Phone+1 650-852-3408
Fax+1 650-858-3978
Dr. Holodniy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Holodniy is based in Palo Alto, CA, and specializes in Infectious Disease with a subspecialty focus on HIV/AIDS Medicine and Microbiology. He completed his fellowship in Infectious Disease at Stanford University and his residency in Internal Medicine at the University of Arizona. Currently, he serves as a Professor of Medicine at Stanford University and the Director of Public Health at the Department of Veterans Affairs, with extensive experience in hepatitis C, HIV/AIDS, microbiology, and influenza. Dr. Holodniy has authored numerous publications, including studies on tuberculosis, HIV, and COVID-19, and has participated in multiple clinical trials such as the Adaptive COVID-19 Treatment Trials. He holds fellowships with the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, and the American College of Physicians.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 1988 - 1991
University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 1985 - 1988
Northwestern University The Feinberg School of MedicineClass of 1985
Certifications & Licensure
CA State Medical License 1987 - 2026
AZ State Medical License 1986 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
American Academy of HIV MedicineHIV Medicine- American Board of Internal MedicineInfectious Diseases
- American Board of Internal MedicineInfectious Diseases
Awards, Honors, & Recognition
- Fellow (FIDSA) Infectious Diseases Society of America, 2005
- Fellow (FSHEA) Society for Healthcare Epidemiology of America, 2005
- Fellow (FACP) American College of Physicians, 1995
Clinical Trials
- Adaptive COVID-19 Treatment Trial (ACTT) Start of enrollment: 2020 Feb 21
- Adaptive COVID-19 Treatment Trial 2 (ACTT-2) Start of enrollment: 2020 May 08
- Adaptive COVID-19 Treatment Trial 3 (ACTT-3) Start of enrollment: 2020 Aug 05
- Join now to see all
Publications & Presentations
PubMed
- Genomic Characterization of RSV in the US by Vaccination Status.Adam S Lauring, Connor Edson, Diya Surie, Fatimah S Dawood, Wesley H Self
JAMA. 2025-03-10 - Risk Factors for Extrapulmonary Tuberculosis Among US Veterans, 1990-2022.Gina Oda, Cynthia Lucero-Obusan, Patricia Schirmer, Joyce Chung, Mark Holodniy
Open Forum Infectious Diseases. 2024-12-01 - An update on drug-drug interactions in older adults living with human immunodeficiency virus (HIV).Rebecca Y Linfield, Nancy N Nguyen, Olivia H Laprade, Mark Holodniy, Aarthi Chary
Expert Review of Clinical Pharmacology. 2024-07-01
Press Mentions
Highly Selective Retrieval of Accurate DNA Utilizing a Pool of in Situ-Replicated DNA from Multiple Next-Generation Sequencing PlatformsApril 20th, 2018
AmpliPhi to Collaborate with the U.S. Department of Veterans Affairs on Expanded Access for Investigational Bacteriophage Therapeutics AB-SA01 and AB-PA01March 13th, 2018
Committees
- Member, IDSA Diagnostics Committee 2017 - 2019
Professional Memberships
- Fellow
- Fellow
- Society for Healthcare Epidemiology of AmericaFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
